Cambridge Healthtech Institute’s 7th Annual

Accelerating Analytical Development

Optimizing the Speed and Efficiency of Key Analytical Steps in Biotherapeutic Development

August 26-27, 2020


Research for this meeting revealed that industry analytical groups are facing increased pressure to deliver key analytical studies faster than ever before – and at lower costs. Cambridge Healthtech Institute’s 7th Annual Accelerating Analytical Development conference offers a best practices forum in which industry scientists and managers can exchange ideas on strategies, new technologies, and the integration of analytical methods in support of these goals. The conference will address the most important roles of the analytical function from early development through GMP release testing and provide insights on how different organizations are addressing these challenges.

Preliminary Agenda

KEYNOTE PRESENTATION: Automation to Support Analytics for Late Stage Process Development

Shelley Elvington, PhD, Associate Director, Genentech


Implementing LC-MS Multi-Attribute Monitoring (MAM) for Biologics In-Process Support

Lei Wang, PhD., Senior Scientist, Analytical Development, Takeda Boston

Replacing Analytical Methods for Registered Products

Dirk Haubert, PhD, Analytical Project Lead, Biologics, Novartis, Switzerland

Analytical Development Workflow for Lifecycle Management of Biologics Products

Udayanath Aich, PhD, Associate Director, Analytical Science and Technology, Bristol-Myers Squibb

Platform Analytical Approaches for Characterization and Purification of Polyethylene Glycols (PEGs) for Bioconjugation

Shuwen Sun, PhD, Associate Principal Scientist, Analytical Research & Development, Merck & Co., Inc.


Development of A Sensitive, Robust and Versatile Native LC-MS Platform for the Characterization of Biologics

Yuetian Yan, PhD, Staff Scientist, Regeneron Pharmaceuticals

Analytical Method Validation and Transfer Challenges

Mohammad Hamzavi, PhD, Scientist, Analytical Development, Genentech

Consideration of Historic Knowledge in Analytical Development: Is the New Tool Able to Detect an Old Issue?

Elena Smith, PhD, Deputy Director, Quality Control, Sanofi Pasteur

Case Study: Analytical Development for a Co-formulated Vaccine

Vaneet Sharma, PhD, Manager, Analytical Development, CMC External Manufacturing, International AIDS Vaccine Initiative


High Throughput Potency Assay of Monoclonal Antibody using Enhanced Up-Conversion Nanoparticle-Based Luminescence Resonance Energy Transfer with 3-D Hydrogel Encapsulation

Jin-Hee Hann, PhD, Senior Scientist, Biologics, Analytical and Research Development, Merck

Sample Prep Automation for Rapifluor-MS N-Glycan Kit and Capillary Electrophoresis Sodium Dodecyl Sulfate (CE-SDS)

Ruchir Shah, Scientist, Process Development Analytics, Bristol-Myers Squibb

One Script to Rule All Analytical Bioassays

Sean Johnston, Scientist, Assay Automation, Strategic Analytics, Biogen


Incorporating in silico Developability Assessments in Early Stages of Biologic Drug Discovery

Stephen R. Comeau, Jr., PhD, Principal Scientist, Computational Antibody & Protein Engineering, Boehringer Ingelheim Pharmaceuticals

New Approaches to Antibody Developability Analysis

Elizabeth Culyba, PhD, Associate Director, Antibody Discovery, Verseau Therapeutics

Predictive Analytics to Accelerate Drug Development

Rajiv Panwar, PhD, Director, CMC Operations, Disc Medicine

For more details on the conference, please contact:
Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute

Phone: (+1) 207-869-9199


For partnering and sponsorship information, please contact:

Companies A-K
Sherry Johnson
Senior Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1359

Companies L-Z
Carolyn Cooke
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412

Premier Sponsors: